Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.90USD
4:00pm EDT
Change (% chg)

$-0.10 (-9.99%)
Prev Close
$1.00
Open
$0.99
Day's High
$0.99
Day's Low
$0.90
Volume
56,330
Avg. Vol
95,106
52-wk High
$4.25
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 7.67 -0.165
FY 2017 Dec '17 7.52 0.325
Sep '17 8.03 -0.029
Jun '17 6.60 -0.140
Mar '17 6.97 -0.507
FY 2016 Dec '16 7.23 -0.147
Sep '16 6.75 -0.227
Jun '16 7.00 -0.277
Mar '16 6.07 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 8.30 8.76 7.85 --
Quarter Ending Sep-18 2 8.81 9.49 8.12 --
Year Ending Dec-18 2 34.22 36.49 31.94 59.70
Year Ending Dec-19 3 49.19 53.51 46.82 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.16 -0.13 -0.18 --
Quarter Ending Sep-18 2 -0.14 -0.12 -0.17 --
Year Ending Dec-18 2 -0.59 -0.49 -0.69 0.09
Year Ending Dec-19 3 -0.24 -0.16 -0.35 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.20 33.54
P/E High - Last 5 Yrs. -- 120.70 47.76
P/E Low - Last 5 Yrs. -- 26.04 25.07
Beta 1.26 0.49 0.79
Price to Sales (TTM) 0.92 10.24 8.28
Price to Book (MRQ) 1.37 4.39 4.21
Price to Tangible Book (MRQ) -- 5.96 6.00
Price to Cash Flow (TTM) 17.63 18.89 22.70
% Owned Institutions 17.29 4.89 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.93 1.74
Dividend Yield - 5 Year Avg -- 0.78 1.43
Dividend 5 Year Growth Rate -- 6.44 -6.29
Payout Ratio(TTM) -- 25.64 41.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 10.06 9.84 5.43
Sales (TTM) vs TTM 1 Yr. Ago 6.71 9.30 12.81
Sales - 5 Yr. Growth Rate 46.59 13.76 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 67.49 16.88 40.97
EPS (TTM) vs TTM 1 Yr. Ago 99.18 -- --
EPS - 5 Yr. Growth Rate -- 7.31 8.04
Capital Spending - 5 Yr. Growth Rate 36.48 10.91 7.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 4.68 2.55
Current Ratio (MRQ) 0.92 4.89 3.62
LT Debt to Equity (MRQ) 3.20 44.90 13.20
Total Debt to Equity (MRQ) 52.21 52.77 17.68
Interest Coverage (TTM) -2.29 30.23 36.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 36.48 42.00 55.10
Gross Margin - 5 Yr. Avg. 31.17 44.27 52.98
EBITD Margin (TTM) -62.56 -- --
EBITD - 5 Yr. Avg -84.63 9.31 15.70
Operating Margin (TTM) -69.64 7.11 -0.37
Operating Margin - 5 Yr. Avg. -92.72 1.79 10.89
Pre-Tax Margin (TTM) -56.55 9.26 1.60
Pre-Tax Margin - 5 Yr. Avg. -101.25 5.51 11.06
Net Profit Margin (TTM) -1.85 6.40 -1.69
Net Profit Margin - 5 Yr. Avg. -77.65 2.88 7.42
Effective Tax Rate (TTM) -- 498.86 29.75
Effective Tax Rate - 5 Yr. Avg. -- 30.35 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,798 3,142,399 727,953,282
Net Income/Employee (TTM) -2,528 76,178 84,747,764
Receivable Turnover (TTM) 2.59 8.92 6.05
Inventory Turnover (TTM) -- 57.40 3.67
Asset Turnover (TTM) 0.66 0.59 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1.23 6.32 10.32
Return on Assets - 5 Yr. Avg. -31.53 6.56 10.99
Return on Investment (TTM) -1.83 7.80 13.09
Return on Investment - 5 Yr. Avg. -40.49 8.26 14.27
Return on Equity (TTM) -2.69 11.13 15.10
Return on Equity - 5 Yr. Avg. -50.47 12.07 15.63
  1 Year 3 Year 5 Year
Sales % 7.66 41.87 46.59
EPS (TTM) % 72.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cancer Genetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.29%
# of Holders: 33
Total Shares Held: 4,796,682
3 Mo. Net Change: -204,074
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 9
# Reduced Positions: 13
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.